ACOD1 and neoplasm: Pioneering work by Ye’s team at Fudan University revealed that the Immune-responsive gene 1 (IRG1)–itaconate axis drives macrophage immunosuppressive reprogramming in tumor microenvironments, subsequently impairing CD8+ T-cell recruitment [112].